Ryan Sanford1, Jeremy Strain2, Mahsa Dadar1, Josefina Maranzano3, Alexandre Bonnet4, Nancy E Mayo5, Susan C Scott5, Lesley K Fellows1, Beau M Ances2, D Louis Collins1. 1. McConnell Brain Imaging Center WB-324, Montreal Neurological Institute, McGill University, Montréal, Québec, Canada. 2. Department of Neurology, Washington University, St. Louis, Missouri, USA. 3. University of Quebec in Trois-Rivieres, Department of Anatomy, Trois-Rivières, Québec, Canada. 4. Service de Neurologie, Centre Hospitalier Universitaire Pontchaillou 2, rue Henri le Guilloux, Rennes Cedex , France. 5. Division of Clinical Epidemiology, McGill University, Montréal, Québec, Canada.
Abstract
OBJECTIVE: The objective of this study is to investigate whether cerebral small vessel disease (CSVD) is more common in virologically suppressed HIV-positive participants compared with HIV-negative controls and examine the potential synergistic effects of HIV and CSVD on brain structure and cognition. DESIGN: Cross-sectional analysis of 119 treated, virologically suppressed HIV-positive and 55 HIV-negative participants. Forty-six HIV-positive and 30 HIV-negative participants had follow-up 2 years later. All participants underwent MRI and neuropsychological testing. METHODS: Volume of white matter hyperintensities (WMH) was used as a surrogate measure of CSVD severity. Tensor-based morphometry and cortical modeling estimated brain volumes and cortical thickness, respectively. Rasch measurement theory was applied to neuropsychological test scores to estimate overall cognition. Linear models compared WMH loads, brain volumes, and cognition between groups; evaluated the association of WMH loads with brain volumes and cognition; and tested the interaction between HIV and WMH loads on brain volumes and cognition. Mixed-effects models compared the change in WMH loads between groups. RESULTS: WMH loads and change in WMH loads were similar between the groups. HIV-positive participants had poorer cognition, thinner cortex and reduced subcortical volumes compared with HIV-negative controls. Higher WMH loads were associated with reduced cortical thickness and subcortical volumes and worse cognition, regardless of HIV serostatus. No significant interactions were observed between HIV and WMH loads with regards to brain volumes or cognition. CONCLUSION: These findings suggest that the contributions of HIV and CSVD on brain atrophy and cognitive impairment are independent but additive processes. This argues that optimizing vascular health may mitigate brain injury and cognitive decline, especially in treated, virologically suppressed HIV-positive individuals.
OBJECTIVE: The objective of this study is to investigate whether cerebral small vessel disease (CSVD) is more common in virologically suppressed HIV-positive participants compared with HIV-negative controls and examine the potential synergistic effects of HIV and CSVD on brain structure and cognition. DESIGN: Cross-sectional analysis of 119 treated, virologically suppressed HIV-positive and 55 HIV-negative participants. Forty-six HIV-positive and 30 HIV-negative participants had follow-up 2 years later. All participants underwent MRI and neuropsychological testing. METHODS: Volume of white matter hyperintensities (WMH) was used as a surrogate measure of CSVD severity. Tensor-based morphometry and cortical modeling estimated brain volumes and cortical thickness, respectively. Rasch measurement theory was applied to neuropsychological test scores to estimate overall cognition. Linear models compared WMH loads, brain volumes, and cognition between groups; evaluated the association of WMH loads with brain volumes and cognition; and tested the interaction between HIV and WMH loads on brain volumes and cognition. Mixed-effects models compared the change in WMH loads between groups. RESULTS:WMH loads and change in WMH loads were similar between the groups. HIV-positive participants had poorer cognition, thinner cortex and reduced subcortical volumes compared with HIV-negative controls. Higher WMH loads were associated with reduced cortical thickness and subcortical volumes and worse cognition, regardless of HIV serostatus. No significant interactions were observed between HIV and WMH loads with regards to brain volumes or cognition. CONCLUSION: These findings suggest that the contributions of HIV and CSVD on brain atrophy and cognitive impairment are independent but additive processes. This argues that optimizing vascular health may mitigate brain injury and cognitive decline, especially in treated, virologically suppressed HIV-positive individuals.
Authors: Lene Ryom; Jens D Lundgren; Wafaa El-Sadr; Peter Reiss; Ole Kirk; Matthew Law; Andrew Phillips; Rainer Weber; Eric Fontas; Antonella d' Arminio Monforte; Stéphane De Wit; Francois Dabis; Camilla I Hatleberg; Caroline Sabin; Amanda Mocroft Journal: Lancet HIV Date: 2018-05-03 Impact factor: 12.767
Authors: A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna Journal: Neurology Date: 2007-10-03 Impact factor: 9.910
Authors: B Aubert-Broche; V S Fonov; D García-Lorenzo; A Mouiha; N Guizard; P Coupé; S F Eskildsen; D L Collins Journal: Neuroimage Date: 2013-05-26 Impact factor: 6.556
Authors: Minjie Wu; Omalara Fatukasi; Shaolin Yang; Jeffery Alger; Peter B Barker; Hoby Hetherington; Tae Kim; Andrew Levine; Eileen Martin; Cynthia A Munro; Todd Parrish; Ann Ragin; Ned Sacktor; Eric Seaberg; James T Becker Journal: AIDS Date: 2018-08-24 Impact factor: 4.177
Authors: Judith S Currier; Jens D Lundgren; Andrew Carr; Daniel Klein; Caroline A Sabin; Paul E Sax; Jeffrey T Schouten; Marek Smieja Journal: Circulation Date: 2008-06-19 Impact factor: 29.690
Authors: Talia R Seider; Assawin Gongvatana; Adam J Woods; Huaihou Chen; Eric C Porges; Tiffany Cummings; Stephen Correia; Karen Tashima; Ronald A Cohen Journal: J Neurovirol Date: 2015-10-07 Impact factor: 2.643
Authors: Tanja Su; Ferdinand W N M Wit; Matthan W A Caan; Judith Schouten; Maria Prins; Gert J Geurtsen; James H Cole; David J Sharp; Edo Richard; Liesbeth Reneman; Peter Portegies; Peter Reiss; Charles B Majoie Journal: AIDS Date: 2016-09-24 Impact factor: 4.177
Authors: Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans Journal: Lancet Neurol Date: 2013-08 Impact factor: 44.182
Authors: Isaac H Solomon; Sukrutha Chettimada; Vikas Misra; David R Lorenz; Robert J Gorelick; Benjamin B Gelman; Susan Morgello; Dana Gabuzda Journal: Mol Neurobiol Date: 2019-11-05 Impact factor: 5.590
Authors: Andrew L Callen; Sara M Dupont; Jeffrey Pyne; Jason Talbott; Phyllis Tien; Evan Calabrese; David Saloner; Felicia C Chow; Jared Narvid Journal: J Neurovirol Date: 2020-06-04 Impact factor: 2.643
Authors: Felicia C Chow; Andrew Callen; Victor Arechiga; David Saloner; Jared Narvid; Priscilla Y Hsue Journal: AIDS Date: 2022-01-01 Impact factor: 4.177
Authors: Brandon J Lew; Mikki D Schantell; Jennifer O'Neill; Brenda Morsey; Tina Wang; Trey Ideker; Susan Swindells; Howard S Fox; Tony W Wilson Journal: Cereb Cortex Date: 2021-07-05 Impact factor: 5.357
Authors: Kyle D Murray; Meera V Singh; Yuchuan Zhuang; Md Nasir Uddin; Xing Qiu; Miriam T Weber; Madalina E Tivarus; Henry Z Wang; Bogachan Sahin; Jianhui Zhong; Sanjay B Maggirwar; Giovanni Schifitto Journal: Front Neurol Date: 2020-12-15 Impact factor: 4.003
Authors: C Bernard; B Dilharreguy; H Font; A Ndoye Diop; J M Tine; I Cissé Diakhate; M Seydi; J F Dartigues; F Dabis; G Catheline; F Bonnet Journal: Int J Infect Dis Date: 2020-12-10 Impact factor: 3.623